Cover Image
Market Research Report

US Procedure Numbers for Orthopedic Biomaterials 2017 - MedPro

Published by iData Research Inc. Product code 454942
Published Content info 459 Pages
Delivery time: 1-2 business days
Price
Back to Top
US Procedure Numbers for Orthopedic Biomaterials 2017 - MedPro
Published: March 1, 2017 Content info: 459 Pages
Description

The full report suite on the U.S. market for orthopedic biomaterials includes bone graft substitutes, which is represented by allografts, demineralized bone matrix, and synthetic bone graft market. The report also includes orthopedic growth factors, cellular allografts, orthopedic cell therapy, hyaluronic acid viscosupplementation, orthopedic cartilage repair, and spinal machined bone allograft markets.

Segments Covered in this Orthopedic Biomaterials Procedure Volume Research

This market study focuses specifically on the volume of procedures in the orthopedic biomaterials market. It includes analysis of procedures in the following segments:

Bone Graft Substitute

Growth Factor Bone Grafts

Cellular Allografts

Cell Therapy

Hyaluronic Acid Injections

Cartilage Repair

Spinal Machined Bone Allografts

This data is then displayed over the forecast period, 2013-2023, outlining the exact growth rates for procedures in these segments. If you're interested in seeing the trends in procedures to formulate your market sizing and forecasts this is the most accurate and most affordable way to do it.

About Procedure Volume Research (MedPro)

Our analysts meticulously research for 3 to 4 months to put together a suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedPro is one portion of that analysis that outlines only the procedure volumes and forecasts for each market in that suite of reports.

This procedural analysis is incorporated in our market size analysis and forecasting which are available when purchasing a MedSuite, MedView or MedCore. For a deeper description on these product types click here or contact us to have a product consultant help you find the data you need.

Where Do We Get Orthopedic Biomaterials Procedure Data?

Our team of analysts has proprietary data that we've been collecting for over a decade as well as government and private databases like that from CMS and hospital records. By looking at multiple sources we are able to triangulate on orthopedic biomaterials procedure volumes that influence and coincide with our overall market sizing.

Trends Affecting the Orthopedic Biomaterials Market

The fastest growing segment in 2016 was the cellular allograft market. This high growth will be slowed due to budgetary constraints that are pushing hospitals to the cheaper allograft procedures. However, due to the therapeutic efficacy of stem cells, they provide greater osteoinductive and osteogenesis properties than other bone grafts, thus improving bone repair. Currently, their use is only considered for the spine, but the market may experience further growth if other indications become approved, such as with the foot where some patients may experience poor vascularization.

Questions This Report will Help You Answer

What is affecting the volume of procedures in the U.S.?

How many procedures were done in 2016?

How many procedures were done historically?

How many procedures can we expect in 2023 and what is the growth trend?

Table of Contents
Product Code: iDATA_USOB17_MP

TABLE OF CONTENTS I

LIST OF FIGURES XVII

LIST OF CHARTS XVIII

EXECUTIVE SUMMARY 1

U.S. ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 4

MARKET TRENDS 6

MARKET DEVELOPMENTS 8

PROCEDURE NUMBERS 9

MARKETS INCLUDED 11

KEY REPORT UPDATES 13

VERSION HISTORY 13

RESEARCH METHODOLOGY 14

  • 1.1 RESEARCH SCOPE 14
  • 1.2 IDATA'S 9-STEP METHODOLOGY 14
    • Step 1: Project Initiation & Team Selection 14
    • Step 2: Prepare Data Systems and Perform Secondary Research 16
    • Step 3: Preparation for Interviews & Questionnaire Design 17
    • Step 4: Performing Primary Research 18
    • Step 5: Research Analysis: Establishing Baseline Estimates 20
    • Step 6: Market Forecast and Analysis 21
    • Step 7: Identify Strategic Opportunities 23
    • Step 8: Final Review and Market Release 24
    • Step 9: Customer Feedback and Market Monitoring 25

DISEASE OVERVIEW 26

  • 2.1 BASIC ANATOMY 26
    • 2.1.1 Osteology and Musculoskeletal System 26
  • 2.2 DISEASE PATHOLOGY AND DISORDERS 28
    • 2.2.1 General Diagnostic 28
    • 2.2.2 Osteoporosis 29
    • 2.2.3 Osteoarthritis 29
    • 2.2.4 Indication for Bone Graft Procedure 30
    • 2.2.5 Indication for Cartilage Repair 31
    • 2.2.6 Degenerative Disc Disease 32
  • 2.3 PATIENT DEMOGRAPHICS 34
    • 2.3.1 General Statistics 34

PROCEDURE NUMBERS 36

  • 3.1 PROCEDURE DEFINITIONS 36
  • 3.2 BONE GRAFT PROCEDURE NUMBERS BY TYPE 37
  • 3.3 BONE GRAFT SUBSTITUTE PROCEDURE NUMBERS 40
    • 3.3.1 By Material 40
    • 3.3.2 By Indication 43
  • 3.4 GROWTH FACTOR BONE GRAFT PROCEDURE NUMBERS 47
  • 3.5 CELLULAR ALLOGRAFT PROCEDURE NUMBERS 49
  • 3.6 CELL THERAPY TREATMENT NUMBERS 51
    • 3.6.1 Platelet-Rich Treatment Numbers by Indication 53
    • 3.6.2 Bone Marrow Concentrate Treatment Numbers by Indication 55
  • 3.7 HYALURONIC ACID TREATMENT NUMBERS BY TYPE 57
  • 3.8 CARTILAGE REPAIR PROCEDURE NUMBERS BY TYPE 60
  • 3.9 SPINAL MACHINED BONE ALLOGRAFT PROCEDURE NUMBERS BY APPROACH 63

ABBREVIATIONS 65

APPENDIX II: COMPANY PRESS RELEASES 67

LIST OF CHARTS

  • Chart 1 1: Orthopedic Biomaterials Market by Segment, U.S., 2013 - 2023 3
  • Chart 1 2: Orthopedic Biomaterials Market Overview, U.S., 2016 & 2023 3
  • Chart 3 1: Bone Graft Procedure Numbers by Type, U.S., 2013 - 2023 39
  • Chart 3 2: Bone Graft Substitute Procedure Numbers by Material, U.S., 2013 - 2023 42
  • Chart 3 3: Bone Graft Substitute Procedure Numbers by Indication, U.S., 2013 - 2023 46
  • Chart 3 4: Growth Factor Bone Graft Procedure Numbers, U.S., 2013 - 2023 48
  • Chart 3 5: Cellular Allograft Procedure Numbers, U.S., 2013 - 2023 50
  • Chart 3 6: Cell Therapy Treatment Numbers by Type, U.S., 2013 - 2023 52
  • Chart 3 7: Platelet-Rich Plasma Treatment Numbers by Indication, U.S., 2013 - 2023 54
  • Chart 3 8: Bone Marrow Concentrate Treatment Numbers by Indication, U.S., 2013 - 2023 56
  • Chart 3 9: Hyaluronic Acid Treatment Numbers by Type, U.S., 2013 - 2023 59
  • Chart 3 10: Cartilage Repair Procedure Numbers by Type, U.S., 2013 - 2023 62
  • Chart 3 11: Spinal Machined Bone Allograft Procedure Numbers by Approach, U.S., 2013 - 2023 64

LIST OF FIGURES

  • Figure 1 1: Orthopedic Biomaterials Market Share Ranking by Segment, U.S., 2016 (1 of 2) 4
  • Figure 1 2: Orthopedic Biomaterials Market Share Ranking by Segment, U.S., 2016 (2 of 2) 4
  • Figure 1 3: Companies Researched in this Report, U.S., 2016 5
  • Figure 1 4: Factors Impacting the Orthopedic Biomaterials Market by Segment, U.S. (1 of 2) 6
  • Figure 1 5: Factors Impacting the Orthopedic Biomaterials Market by Segment, U.S. (2 of 2) 7
  • Figure 1 6: Recent Events in the Orthopedic Biomaterials Market, U.S., 2013 - 2016 8
  • Figure 1 7: Orthopedic Biomaterials Markets Covered, U.S., 2016 (1 of 2) 9
  • Figure 1 8: Orthopedic Biomaterials Markets Covered, U.S., 2016 (2 of 2) 10
  • Figure 1 9: Orthopedic Biomaterials Markets Covered, U.S., 2016(1 of 3) 11
  • Figure 3 1: Bone Graft Procedure Numbers by Type, U.S., 2013 - 2023 38
  • Figure 3 2: Bone Graft Substitute Procedure Numbers by Material, U.S., 2013 - 2023 41
  • Figure 3 3: Bone Graft Substitute Procedure Numbers by Indication, U.S., 2013 - 2023 (1 of 2) 44
  • Figure 3 4: Bone Graft Substitute Procedure Numbers by Indication, U.S., 2013 - 2023 (2 of 2) 45
  • Figure 3 5: Growth Factor Bone Graft Procedure Numbers, U.S., 2013 - 2023 47
  • Figure 3 6: Cellular Allograft Procedure Numbers, U.S., 2013 - 2023 49
  • Figure 3 7: Cell Therapy Treatment Numbers by Type, U.S., 2013 - 2023 51
  • Figure 3 8: Platelet-Rich Plasma Treatment Numbers by Indication, U.S., 2013 - 2023 53
  • Figure 3 9: Bone Marrow Concentrate Treatment Numbers by Indication, U.S., 2013 - 2023 55
  • Figure 3 10: Hyaluronic Acid Treatment Numbers by Type, U.S., 2013 - 2023 58
  • Figure 3 11: Cartilage Repair Procedure Numbers by Type, U.S., 2013 - 2023 61
  • Figure 3 12: Spinal Machined Bone Allograft Procedure Numbers by Approach, U.S., 2013 - 2023 63
  • Figure 5 1: Press Release Summary 67
Back to Top